N-Ethylhexedrone was patented by the German pharmaceutical organization Boehringer Ingelheim in 1964 as a possible anorexigenic agent. The patent describes its synthesis together with other derivatives of aminoketone.[1]N-Ethylhexedrone offers cross-tolerance with all noradrenergic and dopaminergic stimulants, that means that once the consumption o